145 related articles for article (PubMed ID: 38263886)
21. A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease.
Rotin LE; Viswabandya A; Kumar R; Patriquin CJ; Kuo KHM
Hematology; 2023 Dec; 28(1):2163357. PubMed ID: 36728286
[TBL] [Abstract][Full Text] [Related]
22. Cerebrovascular disease in sickle cell disease.
Alakbarzade V; Maduakor C; Khan U; Khandanpour N; Rhodes E; Pereira AC
Pract Neurol; 2023 Apr; 23(2):131-138. PubMed ID: 36123118
[TBL] [Abstract][Full Text] [Related]
23. Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease.
Inam Z; Tisdale JF; Leonard A
Expert Rev Hematol; 2023; 16(11):879-903. PubMed ID: 37800996
[TBL] [Abstract][Full Text] [Related]
24. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
[TBL] [Abstract][Full Text] [Related]
25. Long-term health outcomes following curative therapies for sickle cell disease.
Chakravarthy R; Friedman DL
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):272-276. PubMed ID: 36485115
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.
Locatelli F; Pagliara D
Pediatr Blood Cancer; 2012 Aug; 59(2):372-6. PubMed ID: 22544533
[TBL] [Abstract][Full Text] [Related]
27. Allogeneic hematopoietic stem cell transplant for sickle cell disease: The why, who, and what.
Cimpeanu E; Poplawska M; Jimenez BC; Dutta D; Lim SH
Blood Rev; 2021 Nov; 50():100868. PubMed ID: 34332804
[TBL] [Abstract][Full Text] [Related]
28. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
29. Experiences and Decision Making in Hematopoietic Stem Cell Transplant in Sickle Cell Disease: Patients' and Caregivers' Perspectives.
Khemani K; Ross D; Sinha C; Haight A; Bakshi N; Krishnamurti L
Biol Blood Marrow Transplant; 2018 May; 24(5):1041-1048. PubMed ID: 29196076
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON).
Alonso L; González-Vicent M; Belendez C; Badell I; Sastre A; Rodríguez-Villa A; Bermúdez-Cortés M; Hladun R; Díaz de Heredia C
Med Clin (Barc); 2019 Feb; 152(4):135-140. PubMed ID: 30001893
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
32. An educational symposium for patients with sickle cell disease and their families: results from surveys of knowledge and factors influencing decisions about hematopoietic stem cell transplant.
Thompson AL; Bridley A; Twohy E; Dioguardi J; Sande J; Hsu LL; Kamani N; Meier ER
Pediatr Blood Cancer; 2013 Dec; 60(12):1946-51. PubMed ID: 23900784
[TBL] [Abstract][Full Text] [Related]
33. Improved Quality of Life of Patients With Sickle Cell Disease after Allogeneic Stem Cell Transplant: Another Indication for Transplant.
Aljaafri BA; Albawardi MF; Alghamdi AY; Altowairgi KM; Alhoshan YS; Alahmari B; Alsadi H; Ahmed M; Alnahdi M; Aljubour Z; Alzahrani M
Hematol Oncol Stem Cell Ther; 2023 Jul; 17(1):37-42. PubMed ID: 37581462
[TBL] [Abstract][Full Text] [Related]
34. Severe sickle cell disease--pathophysiology and therapy.
Buchanan G; Vichinsky E; Krishnamurti L; Shenoy S
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S64-7. PubMed ID: 19819341
[TBL] [Abstract][Full Text] [Related]
35. Stem-cell transplantation in children and adults with sickle cell disease: an update.
Khoury R; Abboud MR
Expert Rev Hematol; 2011 Jun; 4(3):343-51. PubMed ID: 21668398
[TBL] [Abstract][Full Text] [Related]
36. Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell Disease.
Nickel RS; Seashore E; Lane PA; Alazraki AL; Horan JT; Bhatia M; Haight AE
Pediatr Blood Cancer; 2016 May; 63(5):908-13. PubMed ID: 26757445
[TBL] [Abstract][Full Text] [Related]
37. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
[TBL] [Abstract][Full Text] [Related]
38. Cerebral hemodynamics and oxygenation in adult patients with sickle cell disease after stem cell transplantation.
Afzali-Hashemi L; Dovern E; Baas KPA; Schrantee A; Wood JC; Nederveen AJ; Nur E; Biemond BJ
Am J Hematol; 2024 Feb; 99(2):163-171. PubMed ID: 37859469
[TBL] [Abstract][Full Text] [Related]
39. The effect of intensity of conditioning regimen on the outcome of HSCT in children with sickle cell disease.
Alsultan A; Abujoub R; Elbashir E; Essa MF
Clin Transplant; 2022 Nov; 36(11):e14787. PubMed ID: 35929611
[TBL] [Abstract][Full Text] [Related]
40. [Bone marrow transplant in patients with sickle cell anaemia. Experience in one centre].
García Morin M; Cela E; Garrido C; Bardón Cancho E; Aguado Del Hoyo A; Pascual C; Pérez-Corral A; Beléndez C
An Pediatr (Barc); 2017 Mar; 86(3):142-150. PubMed ID: 27139367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
